シンバイオ製薬（4582）の空売り残高情報
- 空売り機関
- GOLDMAN SACHS INTERNATIONAL
- JPモルガン証券
- Barclays Capital Securities Ltd
- Citigroup Global Markets Limited
- MERRILL LYNCH INTERNATIONAL
- モルガン・スタンレーMUFG証券
- Nomura International plc
- UBS AG
- Macquarie Bank Limited
- BNP Paribas Financial Markets SNC formerly known as BNP Paribas Arbitrage SNC
- JANE STREET GLOBAL TRADING, LLC
- XTX Markets Pte Ltd
- Evo Fund（Evolution Japan Securities Co., Ltd.）
- 空売り機関 残り10件
空売りポジション
| 日付 | 報告 | 空売残高 | 増減率 | 株式数 |
|---|---|---|---|---|
| 2026 | ||||
| 06/29 | Nomura International plc | 0.36% | -0.23% 義務消失 | 278,777株 -173,559株 |
| 06/26 | Nomura International plc | 0.59% | -0.05% | 452,336株 -41,464株 |
| 06/26 | JPモルガン証券 | 1.02% | +0.12% | 784,651株 +95,700株 |
| 06/25 | Barclays Capital Securities Ltd | 1.45% | +0.14% | 1,112,425株 +112,100株 |
| 06/22 | JPモルガン証券 | 0.9% | +0.1% | 688,951株 +76,700株 |
| 06/19 | Nomura International plc | 0.64% | 再IN | 493,800株 |
| 06/17 | Barclays Capital Securities Ltd | 1.31% | -0.09% | 1,000,325株 -73,700株 |
| 06/17 | Nomura International plc | 0.47% | -0.14% 義務消失 | 362,355株 -109,291株 |
| 06/16 | Nomura International plc | 0.61% | +0.01% | 471,646株 +7,179株 |
| 06/15 | Barclays Capital Securities Ltd | 1.4% | +0.07% | 1,074,025株 +55,000株 |
| 06/15 | JPモルガン証券 | 0.8% | +0.07% | 612,251株 +51,300株 |
| 06/12 | Barclays Capital Securities Ltd | 1.33% | +0.11% | 1,019,025株 +82,800株 |
| 06/11 | Barclays Capital Securities Ltd | 1.22% | +0.13% | 936,225株 +103,300株 |
| 06/11 | Nomura International plc | 0.6% | +0.06% | 464,467株 +45,628株 |
| 06/11 | JPモルガン証券 | 0.73% | +0.09% | 560,951株 +74,400株 |
| 06/10 | Barclays Capital Securities Ltd | 1.09% | -0.01% | 832,925株 -7,200株 |
| 06/10 | Nomura International plc | 0.54% | 再IN | 418,839株 |
| 06/09 | Barclays Capital Securities Ltd | 1.1% | +0.15% | 840,125株 +113,300株 |
| 06/08 | Barclays Capital Securities Ltd | 0.95% | +0.17% | 726,825株 +127,800株 |
| 06/05 | Barclays Capital Securities Ltd | 0.78% | -0.11% | 599,025株 -87,000株 |
| 06/04 | Barclays Capital Securities Ltd | 0.89% | -0.12% | 686,025株 -86,700株 |
| 06/03 | Barclays Capital Securities Ltd | 1.01% | -0.16% | 772,725株 -122,600株 |
| 06/02 | Barclays Capital Securities Ltd | 1.17% | -0.09% | 895,325株 -62,000株 |
| 06/01 | Barclays Capital Securities Ltd | 1.26% | +0.13% | 957,325株 +103,600株 |
| 05/29 | Barclays Capital Securities Ltd | 1.13% | +0.17% | 853,725株 +124,700株 |
| 05/28 | Barclays Capital Securities Ltd | 0.96% | -0.14% | 729,025株 -102,500株 |
| 05/28 | JPモルガン証券 | 0.64% | +0.14% | 486,551株 +108,100株 |
| 05/25 | Barclays Capital Securities Ltd | 1.1% | +0.08% | 831,525株 +56,900株 |
| 05/22 | Barclays Capital Securities Ltd | 1.02% | +0.04% | 774,625株 +31,500株 |
| 05/21 | Barclays Capital Securities Ltd | 0.98% | -0.11% | 743,125株 -80,200株 |
| 05/21 | JPモルガン証券 | 0.5% | 再IN | 378,451株 |
| 05/20 | JPモルガン証券 | 0.49% | -0.1% 義務消失 | 373,251株 -76,800株 |
| 05/19 | Barclays Capital Securities Ltd | 1.09% | -0.18% | 823,325株 -140,400株 |
| 05/18 | Barclays Capital Securities Ltd | 1.27% | -0.12% | 963,725株 -88,900株 |
| 05/15 | Barclays Capital Securities Ltd | 1.39% | -0.07% | 1,052,625株 -49,600株 |
| 05/14 | UBS AG | 0.46% | -0.04% 義務消失 | 354,300株 -26,200株 |
| 05/12 | Barclays Capital Securities Ltd | 1.46% | +0.13% | 1,102,225株 +92,000株 |
| 05/12 | UBS AG | 0.5% | 再IN | 380,500株 |
| 05/08 | Barclays Capital Securities Ltd | 1.33% | -0.13% | 1,010,225株 -96,800株 |
| 05/07 | Barclays Capital Securities Ltd | 1.46% | -0.11% | 1,107,025株 -65,300株 |
| 05/07 | UBS AG | 0.49% | -0.04% 義務消失 | 371,100株 -24,200株 |
| 05/01 | JPモルガン証券 | 0.59% | -0.1% | 450,051株 -65,000株 |
| 04/28 | Barclays Capital Securities Ltd | 1.57% | -0.06% | 1,172,325株 -46,300株 |
| 04/27 | Barclays Capital Securities Ltd | 1.63% | +0.06% | 1,218,625株 +50,300株 |
| 04/27 | JPモルガン証券 | 0.69% | -0.1% | 515,051株 -53,500株 |
| 04/24 | GOLDMAN SACHS INTERNATIONAL | 1.09% | -0.07% | 815,204株 -51,600株 |
| 04/23 | GOLDMAN SACHS INTERNATIONAL | 1.16% | -0.11% | 866,804株 -48,000株 |
| 04/23 | Barclays Capital Securities Ltd | 1.57% | +0.14% | 1,168,325株 +102,300株 |
| 04/23 | UBS AG | 0.53% | 再IN | 395,300株 |
10年以上蓄積したファイナンスデータとAIを掛け合わせて、投資の意思決定を加速させるポジションです。
